{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:36:25Z","timestamp":1793702185799,"version":"4.5.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T00:00:00Z","timestamp":1661558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T00:00:00Z","timestamp":1661558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011946","name":"Abbott Diabetes Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011946","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Continuous glucose monitoring (CGM) shows in more detail the glycaemic pattern of diabetic subjects and provides several new parameters (\u201cglucometrics\u201d) to assess patients\u2019 glycaemia and consensually guide treatment. A better control of glucose levels might result in improvement of clinical outcome and reduce disease complications. This study aimed to gather an expert consensus on the clinical and prognostic use of CGM in diabetic patients at high cardiovascular risk or with heart disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A list of 22 statements concerning type of patients who can benefit from CGM, prognostic impact of CGM in diabetic patients with heart disease, CGM use during acute cardiovascular events and educational issues of CGM were developed. Using a two-round Delphi methodology, the survey was distributed online to 42 Italian experts (21 diabetologists and 21 cardiologists) who rated their level of agreement with each statement on a 5-point Likert scale. Consensus was predefined as more than 66% of the panel agreeing\/disagreeing with any given statement.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Forty experts (95%) answered the survey. Every statement achieved a positive consensus. In particular, the panel expressed the feeling that CGM can be prognostically relevant for every diabetic patient (70%) and that is clinically useful also in the management of those with type 2 diabetes not treated with insulin (87.5%). The assessment of\u00a0time in range (TIR)<jats:italic>,<\/jats:italic>glycaemic variability (GV) and hypoglycaemic\/hyperglycaemic episodes were considered relevant in the management of diabetic patients with heart disease (92.5% for TIR, 95% for GV, 97.5% for time spent in hypoglycaemia) and can improve the prognosis of those with ischaemic heart disease (100% for hypoglycaemia, 90% for hyperglycaemia) or with heart failure (87.5% for hypoglycaemia, 85% for TIR, 87.5% for GV). The experts retained that CGM can be used and can impact the short- and long-term prognosis during an acute cardiovascular event. Lastly, CGM has a recognized educational role for diabetic subjects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>According to this Delphi consensus, the clinical and prognostic use of CGM in diabetic patients at high cardiovascular risk is promising and deserves dedicated studies to confirm the experts\u2019 feelings.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12933-022-01598-2","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T16:02:59Z","timestamp":1661616179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus"],"prefix":"10.1186","volume":"21","author":[{"given":"Carlo","family":"Di Mario","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano A.","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Mannucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Marenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Sciatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Pitocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Expert Panel Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Avogaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Bertuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Bonora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Buzzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Carugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Capodanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Consoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Danesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bartolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano Maria De","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Favale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Giorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giorgino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Girelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Golino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Grigioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Indolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Irace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Lovati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Maffettone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Masulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio G","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Oltrona Visconti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Orsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uberto","family":"Pagotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Paloscia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Parati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Piccirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Pozzilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Purrello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Ribichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rubboli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Senni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Tubili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Uguccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,27]]},"reference":[{"issue":"14","key":"1598_CR1","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"DM Nathan","year":"1993","unstructured":"Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C, Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977\u201386.","journal-title":"N Engl J Med."},{"key":"1598_CR2","doi-asserted-by":"crossref","unstructured":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837\u201353.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"1598_CR3","doi-asserted-by":"crossref","unstructured":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):854\u201365. Erratum in: Lancet. 1998;352(9139):1558.","DOI":"10.1016\/S0140-6736(98)07037-8"},{"issue":"6","key":"1598_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1056\/NEJM200002103420603","volume":"342","author":"JM Lachin","year":"2000","unstructured":"Lachin JM, Genuth S, Cleary P, Davis MD, Nathan DM, Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342(6):381\u20139.","journal-title":"N Engl J Med."},{"issue":"19","key":"1598_CR5","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1001\/jama.287.19.2563","volume":"287","author":"Writing Team for the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group","year":"2002","unstructured":"Writing Team for the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA. 2002;287(19):2563\u20139.","journal-title":"JAMA"},{"issue":"5","key":"1598_CR6","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2337\/dc15-1990","volume":"39","author":"Diabetes Control and Complications Trial (DCCT)\/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group","year":"2016","unstructured":"Diabetes Control and Complications Trial (DCCT)\/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT\/EDIC study 30-year follow-up. Diabetes Care. 2016;39(5):686\u201393.","journal-title":"Diabetes Care"},{"issue":"1","key":"1598_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2016-000342","volume":"5","author":"P Mostr\u00f6m","year":"2017","unstructured":"Mostr\u00f6m P, Ahl\u00e9n E, Imberg H, Hansson PO, Lind M. Adherence of self-monitoring of blood glucose in persons with type 1 diabetes in Sweden. BMJ Open Diabetes Res Care. 2017;5(1): e000342.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"12","key":"1598_CR8","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.2337\/dci17-0043","volume":"40","author":"JR Petrie","year":"2017","unstructured":"Petrie JR, Peters AL, Bergenstal RM, Holl RW, Fleming GA, Heinemann L. Improving the clinical value and utility of CGM systems: issues and recommendations: a joint statement of the European association for the study of diabetes and the American Diabetes association diabetes technology working group. Diabetes Care. 2017;40(12):1614\u201321.","journal-title":"Diabetes Care"},{"issue":"1","key":"1598_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.17925\/USE.2012.08.01.27","volume":"8","author":"SR Patton","year":"2012","unstructured":"Patton SR, Clements MA. Continuous glucose monitoring versus self-monitoring of blood glucose in children with type 1 diabetes- are there pros and cons for both? US Endocrinol. 2012;8(1):27\u20139.","journal-title":"US Endocrinol"},{"issue":"12","key":"1598_CR10","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2337\/dc17-1600","volume":"40","author":"T Danne","year":"2017","unstructured":"Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ 3rd, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, N\u00f8rgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, Phillip M. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017;40(12):1631\u201340.","journal-title":"Diabetes Care"},{"issue":"8","key":"1598_CR11","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, N\u00f8rgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593\u2013603.","journal-title":"Diabetes Care"},{"issue":"3","key":"1598_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(18)30136-0","volume":"7","author":"A Ceriello","year":"2019","unstructured":"Ceriello A, Monnier L, Owens D. Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol. 2019;7(3):221\u201330.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"1598_CR13","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s12325-019-0870-x","volume":"36","author":"R Ajjan","year":"2019","unstructured":"Ajjan R, Slattery D, Wright E. Continuous glucose monitoring: a brief review for primary care practitioners. Adv Ther. 2019;36(3):579\u201396.","journal-title":"Adv Ther"},{"issue":"1","key":"1598_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12933-020-01200-7","volume":"20","author":"B Sun","year":"2021","unstructured":"Sun B, Luo Z, Zhou J. Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications. Cardiovasc Diabetol. 2021;20(1):9.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"1598_CR15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.numecd.2019.01.018","volume":"29","author":"D Bruttomesso","year":"2019","unstructured":"Bruttomesso D, Laviola L, Avogaro A, Bonora E, Del Prato S, Frontoni S, Orsi E, Rabbone I, Sesti G, Purrello F, of the Italian Diabetes Society (SID). The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: a consensus view of Italian diabetes experts using the Delphi method. Nutr Metab Cardiovasc Dis. 2019;29(5):421\u201331.","journal-title":"Nutr Metab Cardiovasc Dis."},{"issue":"1","key":"1598_CR16","first-page":"S97","volume":"45","author":"B Draznin","year":"2022","unstructured":"Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D, American Diabetes Association Professional Practice Committee. 7. Diabetes technology: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(1):S97\u2013112.","journal-title":"Diabetes Care"},{"issue":"16","key":"1598_CR17","doi-asserted-by":"publisher","DOI":"10.15420\/ecr.2020.01.R1","volume":"30","author":"T Ahmad","year":"2021","unstructured":"Ahmad T, Riello RJ, Inzucchi SE. A practical guide for cardiologists to the pharmacological treatment of patients with type 2 diabetes and cardiovascular disease. Eur Cardiol. 2021;30(16): e11.","journal-title":"Eur Cardiol"},{"issue":"4","key":"1598_CR18","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1365-2648.2000.t01-1-01567.x","volume":"32","author":"F Hasson","year":"2000","unstructured":"Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs. 2000;32(4):1008\u201315.","journal-title":"J Adv Nurs"},{"key":"1598_CR19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.69864\/ijbsam.9-2.106","volume":"9","author":"L Giannarou","year":"2014","unstructured":"Giannarou L, Zervas E. Using Delphi technique to build consensus in practice. Int J Bus Sci Appl Manage. 2014;9:65\u201382.","journal-title":"Int J Bus Sci Appl Manage"},{"key":"1598_CR20","doi-asserted-by":"publisher","first-page":"677","DOI":"10.12968\/bjtr.1996.3.12.14731","volume":"3","author":"A Walker","year":"1996","unstructured":"Walker A, Selfe J. The Delphi method: a useful tool for the allied health researcher. Br J Therapy and Rehabilitation. 1996;3:677\u201381.","journal-title":"Br J Therapy and Rehabilitation"},{"issue":"5","key":"1598_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1089\/dia.2013.0224","volume":"16","author":"BP Kovatchev","year":"2014","unstructured":"Kovatchev BP, Flacke F, Sieber J, Breton MD. Accuracy and robustness of dynamical tracking of average glycemia (A1c) to provide real-time estimation of hemoglobin A1c using routine self-monitored blood glucose data. Diabetes Technol Ther. 2014;16(5):303\u20139.","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"1598_CR22","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.2337\/diacare.23.12.1830","volume":"23","author":"TS Temelkova-Kurktschiev","year":"2000","unstructured":"Temelkova-Kurktschiev TS, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefeld M. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care. 2000;23(12):1830\u20134.","journal-title":"Diabetes Care"},{"issue":"3","key":"1598_CR23","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1161\/01.CIR.103.3.346","volume":"103","author":"SM Haffner","year":"2001","unstructured":"Haffner SM. Do interventions to reduce coronary heart disease reduce the incidence of type 2 diabetes? A possible role for inflammatory factors. Circulation. 2001;103(3):346\u20137.","journal-title":"Circulation"},{"issue":"2","key":"1598_CR24","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1161\/01.CIR.0000134501.57864.66","volume":"110","author":"K Esposito","year":"2004","unstructured":"Esposito K, Giugliano D, Nappo F, Marfella R, Campanian Postprandial Hyperglycemia Study Group. Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation. 2004;110(2):214\u20139.","journal-title":"Circulation"},{"issue":"14","key":"1598_CR25","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","volume":"295","author":"L Monnier","year":"2006","unstructured":"Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681\u20137.","journal-title":"JAMA"},{"issue":"1","key":"1598_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-002032","volume":"9","author":"M Martinez","year":"2021","unstructured":"Martinez M, Santamarina J, Pavesi A, Musso C, Umpierrez GE. Glycemic variability and cardiovascular disease in patients with type 2 diabetes. BMJ Open Diabetes Res Care. 2021;9(1): e002032.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"6","key":"1598_CR27","first-page":"1659","volume":"79","author":"DJ Cox","year":"1994","unstructured":"Cox DJ, Kovatchev BP, Julian DM, Gonder-Frederick LA, Polonsky WH, Schlundt DG, Clarke WL. Frequency of severe hypoglycemia in insulin-dependent diabetes mellitus can be predicted from self-monitoring blood glucose data. J Clin Endocrinol Metab. 1994;79(6):1659\u201362.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1598_CR28","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/00000542-200608000-00006","volume":"105","author":"M Egi","year":"2006","unstructured":"Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006;105(2):244\u201352.","journal-title":"Anesthesiology"},{"issue":"4","key":"1598_CR29","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00134-010-2129-5","volume":"37","author":"S Eslami","year":"2011","unstructured":"Eslami S, Taherzadeh Z, Schultz MJ, Abu-Hanna A. Glucose variability measures and their effect on mortality: a systematic review. Intensive Care Med. 2011;37(4):583\u201393.","journal-title":"Intensive Care Med"},{"issue":"10057","key":"1598_CR30","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/S0140-6736(16)31535-5","volume":"388","author":"J Bolinder","year":"2016","unstructured":"Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kr\u00f6ger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388(10057):2254\u201363.","journal-title":"Lancet"},{"issue":"1","key":"1598_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13300-016-0223-6","volume":"8","author":"T Haak","year":"2017","unstructured":"Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter open-label randomized controlled trial. Diabetes Ther. 2017;8(1):55\u201373.","journal-title":"Diabetes Ther"},{"issue":"1","key":"1598_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13098-021-00654-3","volume":"13","author":"M Krakauer","year":"2021","unstructured":"Krakauer M, Botero JF, Lavalle-Gonz\u00e1lez FJ, Proietti A, Barbieri DE. A review of flash glucose monitoring in type 2 diabetes. Diabetol Metab Syndr. 2021;13(1):42.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"1598_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s13300-019-00720-0","volume":"11","author":"M Evans","year":"2020","unstructured":"Evans M, Welsh Z, Ells S, Seibold A. The impact of flash glucose monitoring on glycaemic control as measured by HbA1c: a meta-analysis of clinical trials and real-world observational studies. Diabetes Ther. 2020;11(1):83\u201395.","journal-title":"Diabetes Ther"},{"key":"1598_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.diabres.2017.12.015","volume":"137","author":"TC Dunn","year":"2018","unstructured":"Dunn TC, Xu Y, Hayter G, Ajjan RA. Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: a European analysis of over 60 million glucose tests. Diabetes Res Clin Pract. 2018;137:37\u201346.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"1598_CR35","doi-asserted-by":"publisher","first-page":"301","DOI":"10.31083\/j.rcm2202038","volume":"22","author":"E Abuelgasim","year":"2021","unstructured":"Abuelgasim E, Shah S, Abuelgasim B, Soni N, Thomas A, Elgasim M, Harky A. Clinical overview of diabetes mellitus as a risk factor for cardiovascular death. Rev Cardiovasc Med. 2021;22(2):301\u201314.","journal-title":"Rev Cardiovasc Med"},{"issue":"5","key":"1598_CR36","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.2337\/db08-0063","volume":"57","author":"A Ceriello","year":"2008","unstructured":"Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M, Giugliano D. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008;57(5):1349\u201354.","journal-title":"Diabetes"},{"issue":"7","key":"1598_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.570553","volume":"18","author":"NMJ Hanssen","year":"2020","unstructured":"Hanssen NMJ, Kraakman MJ, Flynn MC, Nagareddy PR, Schalkwijk CG, Murphy AJ. Postprandial glucose spikes, an important contributor to cardiovascular disease in diabetes? Front Cardiovasc Med. 2020;18(7): 570553.","journal-title":"Front Cardiovasc Med"},{"issue":"6865","key":"1598_CR38","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(6865):813\u201320.","journal-title":"Nature"},{"issue":"9677","key":"1598_CR39","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/S0140-6736(09)60697-8","volume":"373","author":"KK Ray","year":"2009","unstructured":"Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, Erqou S, Sattar N. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet. 2009;373(9677):1765\u201372.","journal-title":"Lancet"},{"issue":"343","key":"1598_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4169","volume":"26","author":"R Boussageon","year":"2011","unstructured":"Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, Lafont S, Bergeonneau C, Kassa\u00ef B, Erpeldinger S, Wright JM, Gueyffier F, Cornu C. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ. 2011;26(343): d4169.","journal-title":"BMJ"},{"issue":"24","key":"1598_CR41","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1161\/CIRCULATIONAHA.115.015946","volume":"132","author":"KA Connelly","year":"2015","unstructured":"Connelly KA, Yan AT, Leiter LA, Bhatt DL, Verma S. Cardiovascular implications of hypoglycemia in diabetes mellitus. Circulation. 2015;132(24):2345\u201350.","journal-title":"Circulation"},{"issue":"19","key":"1598_CR42","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1161\/CIRCULATIONAHA.107.188965","volume":"117","author":"DD Schocken","year":"2008","unstructured":"Schocken DD, Benjamin EJ, Fonarow GC, Krumholz HM, Levy D, Mensah GA, Narula J, Shor ES, Young JB, Hong Y, American Heart Association Council on Epidemiology and Prevention; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Nursing; American Heart Association Council on High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; Functional Genomics and Translational Biology Interdisciplinary Working Group. Prevention of heart failure: a scientific statement from the American heart association councils on epidemiology and prevention, clinical cardiology, cardiovascular nursing, and high blood pressure research; quality of care and outcomes research interdisciplinary working group; and functional genomics and translational biology interdisciplinary working group. Circulation. 2008;117(19):2544\u201365.","journal-title":"Circulation"},{"issue":"1","key":"1598_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/CIRCIMAGING.109.855510","volume":"3","author":"MK Poulsen","year":"2010","unstructured":"Poulsen MK, Henriksen JE, Dahl J, Johansen A, Gerke O, Vach W, Haghfelt T, H\u00f8ilund-Carlsen PF, Beck-Nielsen H, M\u00f8ller JE. Left ventricular diastolic function in type 2 diabetes mellitus: prevalence and association with myocardial and vascular disease. Circ Cardiovasc Imaging. 2010;3(1):24\u201331.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"1598_CR44","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jchf.2014.08.004","volume":"3","author":"A Dei Cas","year":"2015","unstructured":"Dei Cas A, Khan SS, Butler J, Mentz RJ, Bonow RO, Avogaro A, Tschoepe D, Doehner W, Greene SJ, Senni M, Gheorghiade M, Fonarow GC. Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure. JACC Heart Fail. 2015;3(2):136\u201345.","journal-title":"JACC Heart Fail"},{"issue":"1","key":"1598_CR45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ejhf.633","volume":"19","author":"DH Fitchett","year":"2017","unstructured":"Fitchett DH, Udell JA, Inzucchi SE. Heart failure outcomes in clinical trials of glucose-lowering agents in patients with diabetes. Eur J Heart Fail. 2017;19(1):43\u201353.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"1598_CR46","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tsch\u00f6pe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62(4):263\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"1598_CR47","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1056\/NEJMcibr1913825","volume":"382","author":"WJ Paulus","year":"2020","unstructured":"Paulus WJ. Unfolding discoveries in heart failure. N Engl J Med. 2020;382(7):679\u201382.","journal-title":"N Engl J Med"},{"key":"1598_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3484","author":"S Tremamunno","year":"2021","unstructured":"Tremamunno S, De Vita A, Villano A, Melita V, Ingrasciotta G, Ruscio E, Filice M, Bisignani A, Ravenna SE, Tartaglione L, Rizzo GE, Di Leo M, Felici T, Pitocco D, Lanza GA. Relation of endothelial and cardiac autonomic function with left ventricle diastolic function in patients with type 2 diabetes mellitus. Diabetes Metab Res Rev. 2021. https:\/\/doi.org\/10.1002\/dmrr.3484.","journal-title":"Diabetes Metab Res Rev"},{"issue":"15","key":"1598_CR49","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Brueckmann M, Jamal W, Kimura K, Schnee J, Zeller C, Cotton D, Bocchi E, B\u00f6hm M, Choi DJ, Chopra V, Chuquiure E, Giannetti N, Janssens S, Zhang J, Gonzalez Juanatey JR, Kaul S, Brunner-La Rocca HP, Merkely B, Nicholls SJ, Perrone S, Pina I, Ponikowski P, Sattar N, Senni M, Seronde MF, Spinar J, Squire I, Taddei S, Wanner C, Zannad F, EMPEROR-Reduced Trial Investigators. Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med. 2020;383(15):1413\u201324.","journal-title":"N Engl J Med"},{"issue":"21","key":"1598_CR50","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, K\u00f8ber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, B\u011blohl\u00e1vek J, B\u00f6hm M, Chiang CE, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, Duk\u00e1t A, Ge J, Howlett JG, Katova T, Kitakaze M, Ljungman CEA, Merkely B, Nicolau JC, O\u2019Meara E, Petrie MC, Vinh PN, Schou M, Tereshchenko S, Verma S, Held C, DeMets DL, Docherty KF, Jhund PS, Bengtsson O, Sj\u00f6strand M, Langkilde AM, DAPA-HF Trial Committees and Investigators. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381(21):1995\u20132008.","journal-title":"N Engl J Med."},{"issue":"8","key":"1598_CR51","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.amjcard.2014.07.031","volume":"114","author":"TA Rousan","year":"2014","unstructured":"Rousan TA, Pappy RM, Chen AY, Roe MT, Saucedo JF. Impact of diabetes mellitus on clinical characteristics, management, and in-hospital outcomes in patients with acute myocardial infarction (from the NCDR). Am J Cardiol. 2014;114(8):1136\u201344.","journal-title":"Am J Cardiol"},{"issue":"7","key":"1598_CR52","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.2337\/dc19-0047","volume":"42","author":"G Marenzi","year":"2019","unstructured":"Marenzi G, Cosentino N, Genovese S, Campodonico J, De Metrio M, Rondinelli M, Cornara S, Somaschini A, Camporotondo R, Demarchi A, Milazzo V, Moltrasio M, Rubino M, Marana I, Grazi M, Lauri G, Bonomi A, Veglia F, De Ferrari GM, Bartorelli AL. Reduced cardio-renal function accounts for most of the in-hospital morbidity and mortality risk among patients with type 2 diabetes undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Diabetes Care. 2019;42(7):1305\u201311.","journal-title":"Diabetes Care"},{"issue":"6","key":"1598_CR53","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.ahj.2010.09.022","volume":"160","author":"G Marenzi","year":"2010","unstructured":"Marenzi G, De Metrio M, Rubino M, Lauri G, Cavallero A, Assanelli E, Grazi M, Moltrasio M, Marana I, Campodonico J, Discacciati A, Veglia F, Bartorelli AL. Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary intervention. Am Heart J. 2010;160(6):1170\u20137.","journal-title":"Am Heart J"},{"issue":"9","key":"1598_CR54","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1001\/archinte.164.9.982","volume":"164","author":"I Stranders","year":"2004","unstructured":"Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twisk JW, Heine RJ, Visser FC. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med. 2004;164(9):982\u20138.","journal-title":"Arch Intern Med"},{"issue":"15","key":"1598_CR55","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1001\/jama.2009.496","volume":"301","author":"M Kosiborod","year":"2009","unstructured":"Kosiborod M, Inzucchi SE, Goyal A, Krumholz HM, Masoudi FA, Xiao L, Spertus JA. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA. 2009;301(15):1556\u201364.","journal-title":"JAMA"},{"issue":"1","key":"1598_CR56","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jacc.2005.03.052","volume":"46","author":"DS Pinto","year":"2005","unstructured":"Pinto DS, Skolnick AH, Kirtane AJ, Murphy SA, Barron HV, Giugliano RP, Cannon CP, Braunwald E, Gibson CM, TIMI Study Group. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005;46(1):178\u201380.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1598_CR57","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.2337\/db13-0468","volume":"63","author":"E Chow","year":"2014","unstructured":"Chow E, Bernjak A, Williams S, Fawdry RA, Hibbert S, Freeman J, Sheridan PJ, Heller SR. Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk. Diabetes. 2014;63(5):1738\u201347.","journal-title":"Diabetes"},{"issue":"9","key":"1598_CR58","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S2213-8587(15)00223-5","volume":"3","author":"D Mesotten","year":"2015","unstructured":"Mesotten D, Preiser JC, Kosiborod M. Glucose management in critically ill adults and children. Lancet Diabetes Endocrinol. 2015;3(9):723\u201333.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"1598_CR59","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1253\/circj.CJ-12-0303","volume":"76","author":"I Teraguchi","year":"2012","unstructured":"Teraguchi I, Imanishi T, Ozaki Y, Tanimoto T, Kitabata H, Ino Y, Ishibashi K, Komukai K, Hirata K, Akasaka T. Impact of stress hyperglycemia on myocardial salvage following successfully recanalized primary acute myocardial infarction. Circ J. 2012;76(11):2690\u20136.","journal-title":"Circ J"},{"issue":"4","key":"1598_CR60","doi-asserted-by":"publisher","first-page":"674","DOI":"10.2337\/dc18-2047","volume":"42","author":"E Gerbaud","year":"2019","unstructured":"Gerbaud E, Darier R, Montaudon M, Beauvieux MC, Coffin-Boutreux C, Coste P, Douard H, Ouattara A, Catargi B. Glycemic variability is a powerful independent predictive factor of midterm major adverse cardiac events in patients with diabetes with acute coronary syndrome. Diabetes Care. 2019;42(4):674\u201381.","journal-title":"Diabetes Care"},{"issue":"7","key":"1598_CR61","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.2337\/dc18-0166","volume":"42","author":"M Yaron","year":"2019","unstructured":"Yaron M, Roitman E, Aharon-Hananel G, Landau Z, Ganz T, Yanuv I, Rozenberg A, Karp M, Ish-Shalom M, Singer J, Wainstein J, Raz I. Effect of flash glucose monitoring technology on glycemic control and treatment satisfaction in patients with type 2 diabetes. Diabetes Care. 2019;42(7):1178\u201384.","journal-title":"Diabetes Care"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01598-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-022-01598-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01598-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T18:16:37Z","timestamp":1727892997000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-022-01598-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,27]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1598"],"URL":"https:\/\/doi.org\/10.1186\/s12933-022-01598-2","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,27]]},"assertion":[{"value":"13 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study is based on a survey that does not involve the participation of human subjects nor patient data management and does not aim to modify the current clinical practice of participants. Consequently, this study did not require ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"all authors report personal fees from Abbott Diabetes Care, during the conduct of the study. S.G. reports personal fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Hikma Pharmaceuticals, Merck Sharp & Dhome, Molteni Farmaceutici, Novartis, Novo Nordisk, Sanofi, Takeda, Teva, Zentiva, outside the submitted work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"164"}}